GlassScriptPhysician profile
Jose Valle
NPI 1992936488
$50,029.40
in general payments reported to CMS, 2019-2025
16 companies · $46K in 2025
The $46K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2021: $407 · 2022: $1,189 · 2023: $1,015 · 2024: $1,048 · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Consulting Fee: $4,725 · Food and Beverage: $3,593 · Travel and Lodging: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,475.00 |
| Consulting Fee | $4,725.00 |
| Food and Beverage | $3,592.92 |
| Travel and Lodging | $1,518.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $45,290.92 | 2025 | Zepbound, Mounjaro |
| Inspire Medical Systems, INC. | $1,861.61 | 2022-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $721.77 | 2019-2025 | Xywav |
| Glaxosmithkline, LLC. | $468.31 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inari Medical, INC. | $379.76 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Avadel Cns Pharmaceuticals, LLC | $364.32 | 2023-2025 | Lumryz |
| Harmony Biosciences LLC | $249.14 | 2023-2024 | Wakix |
| Intuitive Surgical, INC. | $194.50 | 2024-2025 | |
| Insmed, INC. | $142.57 | 2022-2025 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2022 | |
| United Therapeutics Corporation | $105.27 | 2025 | |
| Merck Sharp & Dohme LLC | $34.04 | 2025 | Winrevair |
| Vapotherm INC | $28.77 | 2022 | |
| Medtronic, INC. | $26.63 | 2025 | Nuvent |
| Pulmonx Corporation | $19.38 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Valle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.